pI: 10.1837 |
Length (AA): 639 |
MW (Da): 73791 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129472)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_II002000 | phospholipase D active site motif family protein |
Cryptosporidium hominis | Chro.30333 | cardiolipin synthetase |
Cryptosporidium parvum | cgd3_2940 | probable phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthase, 2x SMART_PLDc domains, possible bacterial origin |
Chlamydia trachomatis | CT_284 | phospholipase D superfamily protein |
Dictyostelium discoideum | DDB_G0284687 | phospholipase D |
Escherichia coli | b0789 | cardiolipin synthase 2 |
Escherichia coli | b1249 | cardiolipin synthase 1 |
Leishmania braziliensis | LbrM.20.1600 | cardiolipin synthetase, putative |
Leishmania donovani | LdBPK_341860.1 | cardiolipin synthetase, putative |
Leishmania infantum | LinJ.34.1860 | cardiolipin synthetase, putative |
Leishmania major | LmjF.34.2110 | cardiolipin synthetase, putative |
Leishmania mexicana | LmxM.33.2110 | cardiolipin synthetase, putative |
Neospora caninum | NCLIV_068780 | hypothetical protein |
Neospora caninum | NCLIV_054060 | hypothetical protein |
Plasmodium berghei | PBANKA_0108000 | mitochondrial cardiolipin synthase, putative |
Plasmodium falciparum | PF3D7_0609400 | mitochondrial cardiolipin synthase, putative |
Plasmodium knowlesi | PKNH_1140800 | mitochondrial cardiolipin synthase, putative |
Plasmodium vivax | PVX_113625 | cardiolipin synthetase, putative |
Plasmodium yoelii | PY06901 | cardiolipin synthetase |
Trypanosoma brucei gambiense | Tbg972.4.2520 | cardiolipin synthetase, putative |
Trypanosoma brucei | Tb927.4.2560 | cardiolipin synthetase |
Trypanosoma brucei | Tb11.v5.0672 | cardiolipin synthetase, putative |
Trypanosoma congolense | TcIL3000_4_2440 | cardiolipin synthetase, putative |
Trypanosoma cruzi | TcCLB.506631.20 | cardiolipin synthetase, putative |
Trypanosoma cruzi | TcCLB.506559.40 | cardiolipin synthetase, putative |
Toxoplasma gondii | TGME49_309940 | phospholipase D active site domain-containing protein |
Theileria parva | TP04_0329 | cardiolipin synthetase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.2560 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.2560 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.2560 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.2560 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0789 | Escherichia coli | non-essential | goodall |
b1249 | Escherichia coli | non-essential | goodall |
TGME49_309940 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
2 literature references were collected for this gene.